JG
ALXA

Jefferies Group’s Alexza Pharmaceuticals Inc ALXA Stock Holding History

Jefferies Group’s Portfolio ALXA Stock Details ALXA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-536,800
Closed -$800K – 2591
2014
Q4 		$800K Hold
536,800
– – ﹤0.01% 1078
2014
Q3 		$1.25M Buy
536,800
+9,000
+2% +$34.4K 0.01% 920
2014
Q2 		$2.41M Buy
527,800
+1,800
+0.3% +$7.77K 0.02% 567
2014
Q1 		$2.33M Buy
526,000
+5,600
+1% +$28.7K 0.02% 558
2013
Q4 		$2.46M Buy
520,400
+45,800
+10% +$225K 0.02% 510
2013
Q3 		$2.43M Sell
474,600
-2,900
-0.6% -$13.6K 0.02% 537
2013
Q2 		$2.07M Buy
+477,500
New +$2.16M 0.02% 491

Other funds holding ALXA

LPA
Lansdowne Partners Austria Vienna, Austria $29M AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
CLOS
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $8.13B AUM 26.03% 1-Year Est. Return
HHMI
Howard Hughes Medical Institute Chevy Chase, Maryland $416M AUM 13.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return